Specialty pharmacy is a small share of prescriptions and a huge share of cost — concentrated in a few owners, and still missing real adherence visibility. Here's the size, the owners, and where it sits.
The size
~$293B
specialty drugs dispensed, 2025 (+9.6% YoY)
~1,900
accredited specialty pharmacies (~5× since 2015)
~2/3
of revenue via the 3 PBM-owned pharmacies
553 · 28%
health-system-operated sites (fastest-growing)
Who owns it — top 10 by revenue
The big-three PBM-owned pharmacies are vertically integrated; the more open tier for an independent platform is health-system and PE-backed pharmacies.
#
Specialty pharmacy
Owner / parent
Tier
1
CVS Specialty
CVS Health
● PBM-owned
2
Accredo / Freedom Fertility
Cigna — Evernorth (Express Scripts)
● PBM-owned
3
Optum Specialty Pharmacy
UnitedHealth Group (Optum Rx)
● PBM-owned
4
Walgreens Specialty (+ stores)
Walgreens Boots Alliance
● Retail
5
Onco360 / CareMed
BrightSpring Health
● Independent / PE
6
PANTHERx Rare
Independent (PE-backed)
● Independent / PE
7
CenterWell Specialty
Humana
● Insurer-owned
8
BioPlus / Paragon Healthcare
Elevance Health (Carelon)
● Insurer-owned
9
AcariaHealth / Foundation Care ★
Centene
● Insurer-owned
10
Walmart Specialty (+ stores)
Walmart
● Retail
● PBM / insurer-owned · ● retail · ● independent / PE · ★ former LIVIT client
Who else walked this path
The technology peers — companies that built adherence or compliance tools. The pattern: almost every one is either a connected device or a software layer. LIVIT's lane was integrating both into a specialty-pharmacy workflow.
Strong analytics & outreach — but no sensing device. They infer adherence; they don't measure the dose.
Integrated, end-to-end
LIVIT — device + connected platform + pharmacist console, sold B2B into specialty pharmacy.
The rare combination: IoT + tech + data as one loop — integration, not a novel sensor.
Companies named descriptively for market context — no affiliation or endorsement implied. Status varies (several are independent, acquired, or wound down).
Where it sits — illustrative state distribution
Illustrative estimate, not a census. The ~1,900 accredited pharmacies allocated across states by the basis you choose (population, 65+, or Medicaid enrollment). Hover a state for detail.
Market figures are from public industry reporting (Drug Channels Institute / Becker's; specialty dispensing ~$293B in 2025, ~1,900 accredited locations, top owners by 2024–2025 revenue). The state map is an illustrative distribution estimate — the national accredited total allocated by population, age, or Medicaid enrollment — not an official per-state count. Company and owner names are referenced descriptively and imply no affiliation or endorsement. SharkDreams, Inc. is a prior venture subject of an SEC matter with a final judgment entered March 2025; nothing here is an offer to sell, or a solicitation to buy, any security or investment. Informational only — not legal, financial, or medical advice.
SHARKDREAMS